Menu

Recent Interviews

Ryan Jackson, CEO, Newlox Gold Ventures Corp.

Ryan Jackson
CEO | Newlox Gold Ventures Corp.
60 Laurie Crescent, V7S 1B7 West Vancouver (CAN)

info@newloxgold.com

+1 778 738 0546

Newlox CEO Ryan Jackson on building a green gold producer with a rapid growth trajectory


Nick Mather, CEO, SolGold PLC

Nick Mather
CEO | SolGold PLC
1 King Street, EC2V 8AU London (GB)

emichael@solgold.com.au

+44 20 3823 2125

SolGold CEO Nick Mather on building a major gold and copper mining company


Jared Scharf, CEO, Desert Gold Ventures Inc.

Jared Scharf
CEO | Desert Gold Ventures Inc.
4770 72nd St,, V4K 3N3 Delta (CAN)

jared.scharf@desertgold.ca

Desert Gold Ventures CEO Jared Scharf on West Africa and its potential


30. October 2020 | 09:37 CET

BioNTech, Newlox Gold, NEL ASA - get in now!

  • Investments
Photo credits: pixabay.com

Germany in a state of shock! After the announcement of a second lockdown and a steadily increasing number of infections, the calls for a vaccine against coronavirus are getting louder and louder. The question is not when, but how quickly it will be available, especially for risk groups. Three Companies are currently heading for the home stretch. The first mover will not only get fame and recognition, but the market value of the Company will go through the roof. After the strong sell-off on the world's stock markets, there are lucrative entry opportunities.

time to read: 2 minutes by Stefan Feulner


 

Author

Stefan Feulner

The native Franconian has more than 20 years of stock exchange experience and a broadly diversified network.
He is passionate about analyzing a wide variety of business models and investigating new trends.

About the author


BioNTech in the pole position

The British Times reported on Wednesday, citing government circles, that the Mainz-based BioNTech could distribute a vaccine before Christmas. This outcome would enable BioNTech and its partner, Pfizer, to outdo the tough competition from the British Company, Astra Zeneca and the US Company, Moderna. Even if it is "only" a lead of two weeks, this will correlate with the assumed positive study results.

Pfizer boss sticks to schedule

Albert Bourda, CEO of Pfizer, recently announced that the Company would apply for emergency approval of its corona vaccine in the United States in November. The FDA approval is conditional on efficacy and safety data being positive in ongoing trials. The US biotech company, Moderna, does not intend to apply for emergency approval until December. After the positive news, BioNTech's share price rose yesterday by over 8% to USD 84.00. The shares were trading at USD 76.00 the day before due to strong selling in the overall market. The high was USD 94.00. If the results remain positive, new highs may only be a matter of time.

The Green Gold

First Mover status has already been achieved by Canadian junior gold production and environmental Company, Newlox Gold Ventures Corp., in the area of sustainably mined gold. The strategy was born by chance. "We were shocked when the results came back from the lab showing that the tailings had a higher grade than the mine plan we were developing at the time..." CEO Ryan Jackson told us in an interview. The reason for the high grade in the tailings was due to decades of artisanal processing, which is only 40% effective in extracting gold.

New focal points set new standards

Newlox Gold, in collaboration with the Norman B. Keevil Institute of Mining Engineering at the University of British Columbia, has developed a customized system for recovering precious metals from artisanal tailings piles, while at the same time carrying out environmental remediation. Artisanal gold accounts for 20% of global gold production. It is a USD 27 billion industry that has been completely neglected by traditional mining companies. The current market capitalization is just CAD 15 million. Newlox has access to 30 historic, prospective gold projects. The fact that Canadians are paying attention to environmental and social aspects is setting new standards, especially in the gold mining industry.

Disappointing stock market debut

The Norwegian hydrogen Company, NEL ASA, is not doing well with partnerships and participations at the moment. The disaster around Nikola, a US fuel cell and battery truck builder, which has been burdened with severe fraud allegations, was already one of the main topics on the capital market this summer. Yesterday came the next, admittedly minor disappointment. The Danish hydrogen Company, Everfuel, celebrated its IPO. NEL ASA still holds 19.9% of the Company, which was spun off in 2019. The placement price was still at NOK 22. However, during the meeting, the price dropped to as low as NOK 15. Considering that hydrogen shares are all the rage at the moment, a bitter disappointment. On the positive side, the Danes were able to place shares worth almost NOK 27 million in a private placement for NOK 22.


Author

Stefan Feulner

The native Franconian has more than 20 years of stock exchange experience and a broadly diversified network.
He is passionate about analyzing a wide variety of business models and investigating new trends.

About the author



Conflict of interest & risk note

In accordance with §34b WpHG we would like to point out that Apaton Finance GmbH as well as partners, authors or employees of Apaton Finance GmbH may hold long or short positions in the aforementioned companies and that there may therefore be a conflict of interest. Apaton Finance GmbH may have a paid contractual relationship with the company, which is reported on in the context of the Apaton Finance GmbH Internet offer as well as in the social media, on partner sites or in e-mail messages. Further details can be found in our Conflict of Interest & Risk Disclosure.


Related comments:

27. November 2020 | 09:19 CET | by Stefan Feulner

BYD, Canadian Solar, Silver Viper - don't miss the start!

  • Investments

The optimism for life in normality is growing more and more with the successful test results concerning the vaccines against the coronavirus. The administration of a vaccine, which is to be available to the general public from spring 2021 onwards, should make it possible to relax increasingly in everyday life. If one reads the daily news, the pandemic seems to be contained and thus controllable within a few months. The "victims" of this development are the crisis currencies gold and silver. After their highs, both precious metals and mining stocks are initially taking a breather - but a comeback is very likely.

Read

25. November 2020 | 11:44 CET | by Nico Popp

Sartorius, Drägerwerk, Desert Gold: Vaccines for the portfolio

  • Investments

The crisis is on the home stretch. Several vaccines have been found and are about to be approved. But it will still take a while before the pandemic is defeated: millions of people need to be vaccinated. Usually, two doses of vaccine are required for this purpose, which must be administered at specific intervals. This Herculean logistical task must succeed in many countries if normality is to be restored. This much seems inevitable: 2021 will still be under the influence of the virus. Corona also leaves its mark on the capital market, whether directly or indirectly.

Read

25. November 2020 | 11:15 CET | by Stefan Feulner

Moderna, Triumph Gold, BioNTech - bet on winners!

  • Investments

Gold has not made it out - for the time being. Due to the decision of the Americans pro Joe Biden and the very successful developments regarding a vaccine against the coronavirus, the precious yellow metal went downhill for the time being. The correction may well continue a little further. However, in the past, these setbacks were lucrative with anti-cyclical entry opportunities. Therefore, one should use the time now to take a closer look at promising gold mines.

Read